| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hexosyltransferases | 28 | 2019 | 40 | 6.880 |
Why?
|
| Membrane Proteins | 37 | 2019 | 919 | 6.150 |
Why?
|
| Endoplasmic Reticulum | 18 | 2019 | 177 | 2.920 |
Why?
|
| Protein Processing, Post-Translational | 12 | 2019 | 268 | 2.290 |
Why?
|
| Saccharomyces cerevisiae Proteins | 14 | 2021 | 449 | 2.070 |
Why?
|
| SEC Translocation Channels | 11 | 2021 | 38 | 2.050 |
Why?
|
| Glycoproteins | 8 | 2019 | 189 | 1.930 |
Why?
|
| Glycosylation | 25 | 2019 | 138 | 1.800 |
Why?
|
| Saccharomyces cerevisiae | 10 | 2021 | 570 | 1.630 |
Why?
|
| Asparagine | 5 | 2019 | 25 | 1.270 |
Why?
|
| Protein Transport | 14 | 2021 | 405 | 1.210 |
Why?
|
| Protein Sorting Signals | 5 | 2013 | 55 | 1.140 |
Why?
|
| Cation Transport Proteins | 3 | 2019 | 22 | 1.030 |
Why?
|
| Protein Biosynthesis | 8 | 2016 | 333 | 0.950 |
Why?
|
| Oligosaccharides | 4 | 2018 | 55 | 0.890 |
Why?
|
| Campylobacter lari | 2 | 2017 | 2 | 0.890 |
Why?
|
| Eukaryotic Cells | 4 | 2019 | 57 | 0.880 |
Why?
|
| Proteins | 5 | 2015 | 764 | 0.870 |
Why?
|
| Ribosomes | 8 | 2018 | 170 | 0.770 |
Why?
|
| Membrane Transport Proteins | 7 | 2013 | 135 | 0.760 |
Why?
|
| Endoplasmic Reticulum, Rough | 2 | 2013 | 5 | 0.760 |
Why?
|
| Models, Molecular | 10 | 2019 | 1162 | 0.670 |
Why?
|
| Signal Recognition Particle | 3 | 2008 | 39 | 0.670 |
Why?
|
| HeLa Cells | 8 | 2019 | 541 | 0.620 |
Why?
|
| Prokaryotic Cells | 1 | 2019 | 6 | 0.590 |
Why?
|
| Lipopolysaccharides | 3 | 2018 | 625 | 0.560 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2019 | 210 | 0.560 |
Why?
|
| Oxidoreductases | 2 | 2017 | 58 | 0.550 |
Why?
|
| Proteomics | 2 | 2019 | 293 | 0.540 |
Why?
|
| Protein Structure, Tertiary | 7 | 2013 | 676 | 0.530 |
Why?
|
| Receptors, Peptide | 3 | 2008 | 34 | 0.530 |
Why?
|
| Substrate Specificity | 7 | 2017 | 341 | 0.530 |
Why?
|
| Hemopexin | 2 | 2014 | 5 | 0.510 |
Why?
|
| HEK293 Cells | 9 | 2019 | 616 | 0.510 |
Why?
|
| Amino Acid Motifs | 5 | 2018 | 156 | 0.510 |
Why?
|
| Congenital Disorders of Glycosylation | 4 | 2019 | 7 | 0.500 |
Why?
|
| Intracellular Membranes | 2 | 2007 | 46 | 0.500 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2008 | 151 | 0.500 |
Why?
|
| Protein Structure, Secondary | 4 | 2012 | 260 | 0.490 |
Why?
|
| Protein Binding | 8 | 2018 | 1640 | 0.460 |
Why?
|
| Bacterial Proteins | 2 | 2017 | 742 | 0.420 |
Why?
|
| Haptoglobins | 1 | 2013 | 13 | 0.400 |
Why?
|
| Benzamides | 3 | 2019 | 69 | 0.400 |
Why?
|
| Homeostasis | 1 | 2016 | 379 | 0.390 |
Why?
|
| Sulfonamides | 3 | 2019 | 136 | 0.380 |
Why?
|
| Fungal Proteins | 3 | 2017 | 152 | 0.370 |
Why?
|
| Crystallography, X-Ray | 4 | 2019 | 419 | 0.360 |
Why?
|
| Polysaccharides | 7 | 2019 | 153 | 0.360 |
Why?
|
| RNA, Fungal | 1 | 2012 | 44 | 0.360 |
Why?
|
| Biocatalysis | 1 | 2011 | 50 | 0.340 |
Why?
|
| Protein Conformation | 5 | 2019 | 792 | 0.330 |
Why?
|
| Fluid Therapy | 2 | 2020 | 46 | 0.320 |
Why?
|
| Vasoconstrictor Agents | 2 | 2020 | 70 | 0.310 |
Why?
|
| Humans | 34 | 2021 | 65140 | 0.310 |
Why?
|
| Protein Folding | 6 | 2018 | 268 | 0.300 |
Why?
|
| Protein Subunits | 3 | 2008 | 169 | 0.300 |
Why?
|
| Protozoan Proteins | 2 | 2007 | 132 | 0.300 |
Why?
|
| Evolution, Molecular | 4 | 2007 | 350 | 0.300 |
Why?
|
| Animals | 22 | 2019 | 21345 | 0.290 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2019 | 61 | 0.270 |
Why?
|
| Cell Line | 6 | 2018 | 2024 | 0.260 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2019 | 81 | 0.260 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2017 | 86 | 0.260 |
Why?
|
| Arsenite Transporting ATPases | 1 | 2007 | 2 | 0.260 |
Why?
|
| Molecular Sequence Data | 6 | 2013 | 1979 | 0.260 |
Why?
|
| Cell Membrane | 3 | 2019 | 506 | 0.250 |
Why?
|
| Kinetics | 3 | 2017 | 760 | 0.250 |
Why?
|
| Amino Acid Sequence | 5 | 2018 | 1589 | 0.250 |
Why?
|
| Transferases | 2 | 2003 | 17 | 0.250 |
Why?
|
| GTP Phosphohydrolases | 2 | 2004 | 64 | 0.250 |
Why?
|
| Escherichia coli Proteins | 1 | 2009 | 277 | 0.240 |
Why?
|
| Mutation, Missense | 3 | 2019 | 190 | 0.240 |
Why?
|
| Catalytic Domain | 3 | 2018 | 201 | 0.240 |
Why?
|
| Protein Modification, Translational | 1 | 2005 | 6 | 0.240 |
Why?
|
| Hospital Mortality | 2 | 2020 | 875 | 0.240 |
Why?
|
| Enzyme Inhibitors | 2 | 2018 | 367 | 0.230 |
Why?
|
| Mutation | 5 | 2017 | 2661 | 0.220 |
Why?
|
| Transfection | 2 | 2017 | 700 | 0.220 |
Why?
|
| Gene Expression | 3 | 2017 | 852 | 0.200 |
Why?
|
| Protein Domains | 2 | 2021 | 154 | 0.190 |
Why?
|
| CRISPR-Cas Systems | 2 | 2017 | 369 | 0.190 |
Why?
|
| RNA Interference | 2 | 2017 | 643 | 0.180 |
Why?
|
| Peptides | 4 | 2017 | 591 | 0.180 |
Why?
|
| Clonidine | 1 | 2021 | 25 | 0.170 |
Why?
|
| Cytosol | 3 | 2017 | 182 | 0.170 |
Why?
|
| Methanococcus | 2 | 2012 | 5 | 0.170 |
Why?
|
| Protein Isoforms | 2 | 2014 | 201 | 0.170 |
Why?
|
| Cryoelectron Microscopy | 3 | 2019 | 217 | 0.170 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2012 | 281 | 0.170 |
Why?
|
| Shock | 1 | 2020 | 33 | 0.160 |
Why?
|
| Structure-Activity Relationship | 4 | 2018 | 355 | 0.150 |
Why?
|
| Shock, Septic | 1 | 2020 | 89 | 0.150 |
Why?
|
| Entamoeba histolytica | 3 | 2008 | 14 | 0.150 |
Why?
|
| Protein Multimerization | 2 | 2018 | 181 | 0.150 |
Why?
|
| von Willebrand Diseases | 1 | 2019 | 4 | 0.150 |
Why?
|
| Escherichia coli | 2 | 2017 | 714 | 0.150 |
Why?
|
| Hemophilia A | 1 | 2019 | 57 | 0.140 |
Why?
|
| Herpes Simplex | 1 | 2019 | 49 | 0.140 |
Why?
|
| Herpesvirus 1, Human | 1 | 2019 | 83 | 0.140 |
Why?
|
| Community Participation | 1 | 2018 | 48 | 0.140 |
Why?
|
| Factor VIII | 1 | 2018 | 32 | 0.140 |
Why?
|
| Conserved Sequence | 1 | 2018 | 173 | 0.140 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2017 | 10 | 0.140 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2017 | 22 | 0.130 |
Why?
|
| Multiple Chronic Conditions | 1 | 2018 | 39 | 0.130 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 268 | 0.130 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 238 | 0.130 |
Why?
|
| RNA, Messenger | 3 | 2013 | 1574 | 0.130 |
Why?
|
| Community Mental Health Services | 1 | 2018 | 95 | 0.130 |
Why?
|
| Ascomycota | 1 | 2017 | 10 | 0.130 |
Why?
|
| Cloning, Molecular | 1 | 2017 | 385 | 0.130 |
Why?
|
| Models, Biological | 2 | 2014 | 1192 | 0.130 |
Why?
|
| Dengue Virus | 1 | 2017 | 99 | 0.120 |
Why?
|
| Lectins | 2 | 2014 | 43 | 0.120 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2016 | 4 | 0.120 |
Why?
|
| Binding Sites | 5 | 2018 | 921 | 0.120 |
Why?
|
| Cell Line, Tumor | 3 | 2016 | 1565 | 0.120 |
Why?
|
| Medical Order Entry Systems | 1 | 2016 | 42 | 0.120 |
Why?
|
| Cellular Senescence | 1 | 2016 | 121 | 0.110 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 710 | 0.110 |
Why?
|
| Plasmids | 1 | 2016 | 294 | 0.110 |
Why?
|
| Genetic Engineering | 1 | 2016 | 113 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 279 | 0.110 |
Why?
|
| Calreticulin | 1 | 2014 | 4 | 0.110 |
Why?
|
| Phenotype | 2 | 2011 | 1233 | 0.110 |
Why?
|
| Cysteine | 1 | 2014 | 108 | 0.100 |
Why?
|
| Intensive Care Units | 3 | 2021 | 420 | 0.100 |
Why?
|
| Base Sequence | 1 | 2016 | 1332 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2020 | 856 | 0.100 |
Why?
|
| Point Mutation | 3 | 2013 | 168 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2011 | 251 | 0.100 |
Why?
|
| Databases, Protein | 1 | 2013 | 45 | 0.100 |
Why?
|
| Presenilins | 1 | 2012 | 4 | 0.090 |
Why?
|
| Presenilin-2 | 1 | 2012 | 20 | 0.090 |
Why?
|
| Presenilin-1 | 1 | 2012 | 66 | 0.090 |
Why?
|
| Molecular Conformation | 2 | 2009 | 115 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2013 | 2188 | 0.090 |
Why?
|
| Models, Genetic | 1 | 2013 | 266 | 0.090 |
Why?
|
| Cathepsin A | 1 | 2011 | 4 | 0.090 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2011 | 11 | 0.090 |
Why?
|
| Depression | 1 | 2018 | 900 | 0.090 |
Why?
|
| Lysosomes | 1 | 2012 | 173 | 0.080 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2011 | 32 | 0.080 |
Why?
|
| Quality of Life | 1 | 2018 | 1260 | 0.080 |
Why?
|
| Mice | 5 | 2018 | 11119 | 0.080 |
Why?
|
| APACHE | 2 | 2020 | 42 | 0.080 |
Why?
|
| Organ Dysfunction Scores | 2 | 2020 | 23 | 0.080 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 981 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2011 | 156 | 0.080 |
Why?
|
| Autophagy | 1 | 2012 | 237 | 0.080 |
Why?
|
| Thermus | 1 | 2009 | 2 | 0.080 |
Why?
|
| Lipid Bilayers | 1 | 2009 | 53 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 203 | 0.070 |
Why?
|
| Gene Knockout Techniques | 2 | 2018 | 97 | 0.070 |
Why?
|
| Protein Precursors | 2 | 2005 | 85 | 0.070 |
Why?
|
| Trichomonas vaginalis | 1 | 2007 | 9 | 0.060 |
Why?
|
| Mannose | 1 | 2007 | 22 | 0.060 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2008 | 127 | 0.060 |
Why?
|
| Dogs | 2 | 2009 | 315 | 0.060 |
Why?
|
| beta-Fructofuranosidase | 1 | 2006 | 2 | 0.060 |
Why?
|
| Trypanosoma cruzi | 1 | 2007 | 53 | 0.060 |
Why?
|
| Permeability | 1 | 2006 | 50 | 0.060 |
Why?
|
| Translocation, Genetic | 1 | 2006 | 74 | 0.060 |
Why?
|
| Homozygote | 2 | 2019 | 122 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 1 | 2006 | 94 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2006 | 104 | 0.060 |
Why?
|
| Yeasts | 1 | 2005 | 47 | 0.060 |
Why?
|
| Cryptococcus neoformans | 1 | 2007 | 142 | 0.060 |
Why?
|
| Metabolic Diseases | 1 | 2005 | 59 | 0.060 |
Why?
|
| Glycosyltransferases | 1 | 2005 | 9 | 0.060 |
Why?
|
| Liposomes | 1 | 2005 | 116 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2005 | 300 | 0.050 |
Why?
|
| Biological Transport | 1 | 2005 | 292 | 0.050 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2003 | 2 | 0.050 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2003 | 2 | 0.050 |
Why?
|
| Guanosine Triphosphate | 1 | 2004 | 54 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2006 | 662 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2003 | 111 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2020 | 3308 | 0.050 |
Why?
|
| Adult | 4 | 2021 | 17358 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 129 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2005 | 394 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2012 | 3153 | 0.050 |
Why?
|
| Phylogeny | 1 | 2003 | 388 | 0.040 |
Why?
|
| Quetiapine Fumarate | 1 | 2021 | 13 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 1630 | 0.040 |
Why?
|
| Central Venous Pressure | 1 | 2020 | 14 | 0.040 |
Why?
|
| Female | 6 | 2020 | 34018 | 0.040 |
Why?
|
| Male | 5 | 2020 | 31047 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2019 | 2061 | 0.040 |
Why?
|
| Computational Biology | 2 | 2018 | 367 | 0.040 |
Why?
|
| Time Factors | 1 | 2008 | 3762 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 5614 | 0.040 |
Why?
|
| Proprotein Convertase 5 | 1 | 2019 | 1 | 0.040 |
Why?
|
| Furin | 1 | 2019 | 10 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2019 | 52 | 0.040 |
Why?
|
| Vero Cells | 1 | 2019 | 81 | 0.040 |
Why?
|
| Health Planning Technical Assistance | 1 | 2018 | 1 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 198 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 174 | 0.040 |
Why?
|
| Psychosocial Support Systems | 1 | 2018 | 12 | 0.040 |
Why?
|
| Exodeoxyribonucleases | 1 | 2018 | 29 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2018 | 130 | 0.030 |
Why?
|
| Middle Aged | 3 | 2020 | 18273 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2018 | 147 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 95 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2020 | 526 | 0.030 |
Why?
|
| Length of Stay | 1 | 2021 | 828 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2018 | 261 | 0.030 |
Why?
|
| CHO Cells | 2 | 2011 | 192 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2018 | 224 | 0.030 |
Why?
|
| Cricetinae | 2 | 2011 | 362 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2016 | 47 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 414 | 0.030 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2016 | 11 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2016 | 79 | 0.030 |
Why?
|
| Adolescent | 2 | 2019 | 6297 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 316 | 0.030 |
Why?
|
| Mental Health | 1 | 2018 | 361 | 0.030 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2016 | 73 | 0.030 |
Why?
|
| Boston | 1 | 2016 | 258 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 2017 | 256 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2019 | 1422 | 0.030 |
Why?
|
| Aged | 2 | 2020 | 14965 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 306 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2018 | 464 | 0.030 |
Why?
|
| Infant | 1 | 2019 | 1693 | 0.030 |
Why?
|
| Consanguinity | 1 | 2013 | 5 | 0.030 |
Why?
|
| Light | 2 | 2005 | 195 | 0.020 |
Why?
|
| Child | 2 | 2019 | 4607 | 0.020 |
Why?
|
| Transferrin | 1 | 2013 | 70 | 0.020 |
Why?
|
| Cathepsin D | 1 | 2012 | 12 | 0.020 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2012 | 13 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1038 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2012 | 41 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 301 | 0.020 |
Why?
|
| Blastocyst | 1 | 2012 | 74 | 0.020 |
Why?
|
| Long QT Syndrome | 1 | 2011 | 31 | 0.020 |
Why?
|
| Cricetulus | 1 | 2011 | 103 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 611 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 513 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 464 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 1050 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2021 | 6872 | 0.020 |
Why?
|
| RNA | 1 | 2012 | 426 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 1392 | 0.020 |
Why?
|
| alpha-Mannosidase | 1 | 2008 | 5 | 0.020 |
Why?
|
| Concanavalin A | 1 | 2008 | 40 | 0.020 |
Why?
|
| Mannosidases | 1 | 2007 | 2 | 0.020 |
Why?
|
| Trichomonas | 1 | 2007 | 2 | 0.020 |
Why?
|
| Carbohydrate Sequence | 1 | 2007 | 21 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2008 | 137 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2012 | 2157 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 133 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2008 | 295 | 0.020 |
Why?
|
| Neurons | 1 | 2012 | 933 | 0.020 |
Why?
|
| Prolactin | 1 | 2005 | 40 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 699 | 0.010 |
Why?
|
| Glycopeptides | 1 | 2005 | 12 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2005 | 118 | 0.010 |
Why?
|
| Cattle | 1 | 2005 | 320 | 0.010 |
Why?
|
| Plasmodium falciparum | 1 | 2007 | 257 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 1113 | 0.010 |
Why?
|
| Species Specificity | 1 | 2005 | 339 | 0.010 |
Why?
|
| Helminth Proteins | 1 | 2003 | 51 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2003 | 193 | 0.010 |
Why?
|
| Alleles | 1 | 2003 | 453 | 0.010 |
Why?
|
| Bacteria | 1 | 2005 | 336 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 422 | 0.010 |
Why?
|